Siegfried Holding
Sebastian Imstepf is a Project Manager for Drug Substance and Analytics at Siegfried Holding AG, with experience in project management in analytical development. Prior to that, Sebastian was a PhD Student/Assistent at the University of Zurich and also worked as a Processor at Lonza. Sebastian has a Ph.D. in Chemistry from the University of Zurich, as well as a Master's degree in Medical Physics and Radiation Therapy from ETH Zurich. Sebastian also has experience as an English Course Instructor and Sales Clerk at Migros-Genossenschafts-Bund.
This person is not in any teams
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.